Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M9,774Revenue $M2,298Net Margin (%)15.0Altman Z-Score8.4
Enterprise Value $M10,331EPS $2.0Operating Margin %17.7Piotroski F-Score7
P/E(ttm)28.0Beneish M-Score-2.0Pre-tax Margin (%)19.0Higher ROA y-yN
Price/Book5.610-y EBITDA Growth Rate %28.2Quick Ratio7.5Cash flow > EarningsN
Price/Sales4.25-y EBITDA Growth Rate %79.4Current Ratio9.9Lower Leverage y-yY
Price/Free Cash Flow283y-y EBITDA Growth Rate %1.9ROA % (ttm)13.0Higher Current Ratio y-yY
Dividend Yield %0.5PEG0.4ROE % (ttm)22.1Less Shares Outstanding y-yY
Payout Ratio %14.0Shares Outstanding M170ROIC % (ttm)18.2Gross Margin Increase y-yY

Gurus Latest Trades with RDY

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
RDYKen Fisher 2015-03-31 Add0.12%$47.73 - $57.1
($53.03)
$ 57.378%Add 25.58%5,216,225
RDYKen Fisher 2014-06-30 Add0.13%$38.67 - $46.08
($42.03)
$ 57.3736%Add 62.43%3,773,114
RDYKen Fisher 2014-03-31 Add0.08%$39.5 - $47.4
($43.29)
$ 57.3733%Add 56.30%2,322,863
RDYKen Fisher 2013-06-30 Add0.04%$32.98 - $38.7
($36.5)
$ 57.3757%Add 48.42%1,283,605
RDYKen Fisher 2013-03-31 Add0.02%$32.03 - $36.57
($34.21)
$ 57.3768%Add 31.46%864,830
RDYKen Fisher 2012-09-30 Buy 0.05%$28.94 - $32.58
($30.12)
$ 57.3790%New holding604,555
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

RDY is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


RDY: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Press Releases about RDY :

Quarterly/Annual Reports about RDY:

    News about RDY:

    Articles On GuruFocus.com
    Emerging Market Stocks To Watch Out For Feb 17 2015 
    Should You Buy Actavis? Mar 18 2014 
    Dr. Reddy’s Laboratories: Should Continue to Gain Market Share in Lucrative Markets May 25 2012 
    5 Mid-Cap Healthcare Dividend Stocks with Perfect Earnings Growth Dec 05 2011 
    Abbott Laboratories and the “India Cure” for the Ailing Pharmaceutical Industry May 26 2010 
    Dr. Reddy’s Q3 FY09 Revenue at Rs. 18,401 million, EBITDA at Rs. 3,453 million, PAT at Rs. 1,924 m Jan 20 2009 

    More From Other Websites
    Dr. Reddy's (RDY) Earnings and Revenues Rise in Q4 - Analyst Blog May 13 2015
    Dr. Reddy’s Q4 & FY15 Financial Results May 12 2015
    Dr.Reddy's Q4 net up 8 percent May 12 2015
    Dr. Reddy's to Release Q4 and Full Year FY15 Results on May 12, 2015 Apr 29 2015
    Dr. Reddy's to Release Q4 and Full Year FY15 Results on May 12, 2015 Apr 29 2015
    3 Large-Cap Pharmaceutical Companies to Invest in Right Now Apr 22 2015
    Curis Presents Preclinical Data on CUDC-427 at AACR Annual Meeting Apr 22 2015
    Curis Presents Preclinical Data on CUDC-427 at AACR Annual Meeting Apr 22 2015
    Curis Announces Presentation of Data from CUDC-427 and IRAK-4 Programs at AACR Annual Meeting Apr 16 2015
    Curis Announces Presentation of Data From CUDC-427 and IRAK-4 Programs at AACR Annual Meeting Apr 14 2015
    Dr Reddy's sees India sales growing 20 percent on new product launches Apr 10 2015
    Dr Reddy's sees India sales growing 20 percent on new product launches Apr 10 2015
    Dr. Reddy’s Laboratories and Its Subsidiary Promius PharmaTM Announce the Filing of Three NDAs... Apr 07 2015
    Dr. Reddy’s Laboratories and Its Subsidiary Promius PharmaTM Announce the Filing of Three NDAs... Apr 07 2015
    Taxus Cardium Announces Agreement With Dr. Reddy's Laboratories To Co-Develop, Market & Sell Generx... Apr 07 2015
    Taxus Cardium Announces Agreement With Dr. Reddy's Laboratories To Co-Develop, Market & Sell Generx... Apr 07 2015
    UCB to Sell Indian Established Brands Portfolio to Dr. Reddy's - Analyst Blog Apr 02 2015
    Sensex rises over 1 percent, posts first weekly gain in four Apr 01 2015
    Sensex rises over 1 percent, posts first weekly gain in four Apr 01 2015
    Dr. Reddy’s Laboratories to Acquire Select Portfolio of the Established Products Business of UCB... Apr 01 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK